Does the granulocyte-macrophage colony-forming unit content in ex vivo- expanded grafts predict the recovery of the recipient leukocytes?

Blood

Volumn 90, Issue 1, 1997, Pages 464-470

  Albella, Beatriz ^a   Segovia, José C ^a   Bueren, Juan A ^a  

^a CIEMAT   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; INTERLEUKIN 1; STEM CELL FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW TRANSPLANTATION; COLONY FORMING UNIT GM; CONTROLLED STUDY; FLOW CYTOMETRY; HEMATOPOIESIS; LEUKOCYTE COUNT; LEUKOPENIA; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL;

EID: 0030997671     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.1.464.464_464_470     Document Type: Article

References (30)

1. Emerson SG: Ex vivo expansion of hematopoietic precursors, progenitors, and stem cells: The next generation of cellular therapeutics. Blood 87:3082, 1996
2. Bernad A, Varas F, Gallego JM, Almendral JM, Bueren JA: Ex vivo expansion and selection of retrovirally transduced bone marrow: An efficient methodology for gene-transfer to murine lympho-hematopoietic stem cells. Br J Haematol 87:6, 1994
3. + peripheral blood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transfer. Blood 85:566, 1995
4. Lu L, Ge Y, Li ZH, Freie B, Clapp DW, Broxmeyer HE: CD34 stem/progenitor cells purified from cryopreserved normal cord blood can be transduced with high efficiency by a retroviral vector and expanded ex vivo with stable integration and expression of Fanconi anemia completation C gene. Cell Transplant 4:493, 1995
5. Varas F, Bernad A, Bueren JA: G-CSF mobilizes into peripheral blood the complete clonal repertoire of hematopoietic precursors residing in the bone marrow of mice. Blood 88:2495, 1996
6. Muench MO, Guy Z, Moore MAS: Ex vivo differentiation therapy as a method of leukemic purging in murine bone marrow expansion cultures. Cancer Res 52:6576, 1992
7. + bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha. J Immunol 154:5851, 1995
8. Okano A, Suzuki C, Takatsuki F, Akiyama Y, Koike K, Ozawa K, Hirano T, Kishimoto T, Nakahata T, Asano S: In vitro expansion of the murine pluripotent hemopoietic stem cell population in response to interleukin 3 and interleukin 6. Transplantation 48:495, 1989
9. Muench MO, Moore MAS: Accelerated recovery of peripheral blood cell counts in mice transplanted with in vitro cytokine-expanded hematopoietic progenitors. Exp Hematol 20:611, 1992
10. Muench MO, Firpo MT, Moore MAS: Bone marrow transplantation with interleukin-1 plus kit-ligand ex vivo expanded bone marrow accelerates hematopoietic reconstitution in mice without the loss of stem cell lineage and proliferative potential. Blood 81:3463, 1993
11. Serrano F, Varas F, Bernad A, Bueren JA: Accelerated and long-term hematopoietic engraftment in mice transplanted with ex vivo expanded bone marrow. Bone Marrow Transplant 14:855, 1994
12. Holyoake TL, Freshney MG, McNair L, Parker AN, McKay PJ, Steward WP, Fitzsimons E, Graham GJ, Pragnell IB: Ex vivo expansion with stem cell factor and interleukin-11 augments both short-term recovery and the ability to serially transplant marrow. Blood 87:4589, 1996
13. Brugger W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L: Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med 333:283, 1995
14. Alcorn MJ, Holyoake TL, Richmond L, Pearson C, Farrell E, Dunlop DJ, Fitzsimons E, Steward WP, Pragnell IP, Franklin IM: CD34-positive cells isolated from cryopreserved peripheral-blood progenitor cells can be expanded ex vivo and used for transplantation with little or no toxicity. J Clin Oncol 14:1839, 1996
15. + cells in serum-free cultures containing steel factor, interleukin-6, and erythropoietin with maintenance of cells with long-term in vivo reconstituting potential. Blood 83:128, 1994
16. +-selected human peripheral blood progenitor cells. Blood 84:2898, 1994
17. Spangrude GJ, Brooks DM, Tumas DB: Long-term repopulation of irradiated mice with limiting numbers of purified hematopoietic stem cells: In vivo expansion of stem cell phenotype but not function. Blood 85:1006, 1995
18. Gabbianelli M, Pelosi E, Montesoro E, Valtieri M, Luchetti L, Samoggia P, Vitelli L, Barberi T, Testa U, Lyman S, Peschle C: Multi-level effects of flt3 ligand on human hematopoiesis: Expansion of putative stem cells and proliferation of granulomonocytic progenitors/monocytic precursors. Blood 86:1661, 1995
19. Koller MR, Palsson MA, Manchel I, Palsson BO: Long-term culture-initiating cell expansion is dependent on frequent medium exchange combined with stromal and other accesory cell effects. Blood 86:1784, 1995
20. Petzer AL, Hogge DE, Lansdorp PM, Reid DS, Eaves CJ: Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium. Proc Natl Acad Sci USA 93:1470, 1996
21. Spitzer G, Verma DS, Fisher R, Zander A, Vellekoop L, Litam J, McCredie KB, Dicke KA: The myeloid pregenitor cell-its value in predicting hematopoietic recovery after autologous bone marrow transplantation. Blood 55:317, 1980
22. Rowley SD, Zuehlsdorf M, Braine HG, Colvin OM, Davis J, Jones RJ, Saral R, Sensenbrenner LL, Yeager A, Santos GW: CFU-GM content of bone marrow graft correlates with time to hematologic reconstitution following autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged bone marrow. Blood 70:271, 1987
23. Jones RJ, Sharkis SJ, Celano P, Colvin OM, Rowley SD, Sensenbrenner LL: Progenitor cell assays predict hematopoietic reconstitution after syngeneic transplantation in mice. Blood 70:1186, 1987
24. Varas F, Bernad A, Almendral JM, Bueren JA: Relevance of myeloablative conditioning in the engraftment of limiting numbers of normal and genetically marked lympho-hematopoietic stem cells. Bone Marrow Transplant 18:981, 1996
25. To LB: Is our current strategy in manipulating hemopoiesis in autologous transplantation correct? Stem Cells 11:283 1993
26. Muench MO, Schneider JG, Moore MAS: Interactions among colony-stimulating factors, IL-1ß, IL-6, and kit-ligand in the regulation of primitive murine hematopoietic cells. Exp Hematol 20:339 1992
27. Ramshaw HS, Rao SS, Crittenden RB, Peters SO, Weier HU, Quesenberry PJ: Engraftment of bone marrow cells into normal unprepared hosts: Effects of 5-fluorouracil and cell cycle status. Blood 86:924 1995
28. Van Der Loo JCM, Ploemacher RE: Marrow- and spleen-seeding efficiencies of all murine hematopoietic stem cell subsets are decreased by preincubation with hematopoietic growth factors. Blood 85:2598, 1995
29. Peters SO, Kittler ELW, Ramshaw HS, Quesenberry PJ: Murine marrow cells expanded in culture with IL-3, IL-6, IL-11, and SCF acquire an engraftment defect in normal hosts. Exp Hematol 23:461, 1995
30. Peters SO, Kittler ELW, Ramshaw HS, Quesenberry PJ: Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood 87:30, 1996